Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.

Solid dispersions of felodipine were formulated with HPMC and surfactants by the conventional solvent evaporation (CSE) and supercritical anti-solvent precipitation (SAS) methods. The solid dispersion particles were characterized by particle size, zeta potential, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), powder X-ray diffraction (XRD), solubility and dissolution studies. The effects of the drug/polymer ratio and surfactants on the solubility of felodipine were also studied. The mean particle size of the solid dispersions was 200-250 nm; these had a relatively regular spherical shape with a narrow size distribution. The particle size of the solid dispersions from the CSE method increased at 1 h after dispersed in distilled water. However, the particle sizes of solid dispersions from the SAS process were maintained for 6 h due to the increased solubility of felodipine. The physical state of felodipine changed from crystalline to amorphous during the CSE and SAS processes, confirmed by DSC/XRD data. The equilibrium solubility of the felodipine solid dispersion prepared by the SAS process was 1.5-20 microg/ml, while the maximum solubility was 35-110 microg/ml. Moreover, the solubility of felodipine increased with decreasing drug/polymer ratio or increasing HCO-60 content. The solid dispersions from the SAS process showed a high dissolution rate of over 90% within 2 h. The SAS process system may be used to enhance solubility or to produce oral dosage forms with high dissolution rate.

[1]  C. Washington,et al.  Chemical stability of total parenteral nutrition mixtures , 1992 .

[2]  K M Park,et al.  Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. , 1999, International journal of pharmaceutics.

[3]  Koji Takahashi,et al.  Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[4]  A. Ellrodt,et al.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. , 1988, Drugs.

[5]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[6]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[7]  Molar solubility of felodipine in different aqueous systems , 1992 .

[8]  Dennis E. Koppel,et al.  Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .

[9]  K. Johnston,et al.  Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. , 2002, International journal of pharmaceutics.

[10]  D. McTavish,et al.  Verapamil , 2012, Drugs.

[11]  B. Edgar,et al.  Felodipine Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.

[12]  Ž. Knez,et al.  Improvement of nifedipine dissolution characteristics using supercritical CO2 , 1997 .

[13]  Jeong-Sook Park,et al.  Solubility enhancers for oral drug delivery , 2004 .

[14]  Sun‐Ho Kang,et al.  Preparation and Characterization of Lysozyme Nanoparticles using Solution Enhanced Dispersion by Supercritical Fluid (SEDS) Process , 2005 .

[15]  Eric Doelker,et al.  Influence of the preparation method on residual solvents in biodegradable microspheres , 1996 .

[16]  Ž. Knez,et al.  Micronization of drugs using supercritical carbon dioxide. , 1999, International journal of pharmaceutics.

[17]  A. Juppo,et al.  Evaluation of controlled-release polar lipid microparticles. , 2002, International journal of pharmaceutics.

[18]  Chong-K. Kim,et al.  Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. , 2002, International journal of pharmaceutics.

[19]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  G. Tytgat,et al.  Gastric Transit and Pharmacodynamics of a Two-Millimeter Enteric-Coated Pancreatin Microsphere Preparation in Patients with Chronic Pancreatitis , 2004, Digestive Diseases and Sciences.

[21]  P. Kleinebudde,et al.  Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process. , 1997, Journal of pharmaceutical sciences.

[22]  Emilio Squillante,et al.  Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. , 2002, Journal of pharmaceutical sciences.

[23]  P. Augustijns,et al.  Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. , 2003, International journal of pharmaceutics.